US6373722023
US6373722023
NRC Health
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 450.09M EUR | 477.55M EUR | 382.67M EUR | 424.9M EUR |
Enterprise Value | 538.8M EUR | 564.25M EUR | 458.16M EUR | 499.8M EUR |
Valuation Multiples | ||||
Trailing P/E | 84.71x | 81.51x | 42.35x | 73.08x |
Forward P/E | 19.36x | -- | -- | -- |
Price to Sales | 3.22x | 3.41x | 2.76x | 4.09x |
Price to Book | 68.68x | 72.92x | 28.36x | 30.37x |
EV/Revenue | 3.85x | 4.03x | 3.3x | 4.81x |
EV/EBITDA | 20.2x | 24.09x | 16.44x | 24.91x |
Price to FCF (P/FCF) | 22.19x | 22.07x | 21.95x | 35.16x |
EV/FCF | 26.57x | 26.07x | 26.29x | 41.36x |
FCF Yield | 4.51% | 4.53% | 4.55% | 2.84% |